On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Reminder test email for the Health and Human Services (HHS) email notifications for WNV reactives wa...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
We are very excited to launch our new website! Please take a few moments to click around and explore...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...